Head and Neck
Study Name: (eVOLVE-HNSCC)
- Cancer Stage: III, IVA, IVB
- Key Inclusion: SCC after Concurrent chemo radiation
- Description: A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Study Number: D798EC00001
- NCT#: NCT06129864
-
Frederick, MD 21702
301-694-5861 More Information -
Frederick, MD 21702
301-663-4774 More Information -
Frederick, MD 21702
240-215-6310 More Information -
Frederick, MD 21702
301-694-5580 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4500 More Information
/
View All